- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01531517
Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (PED111)
Study of the Efficacy of Topical Application of Royal Jelly and Panthenol (PedyPhar® Ointment) on the Diabetic Foot Ulcers, An Open Label, Randomized, Non-placebo-controlled Study
Clinical Trial Phase III-b
Study Sponsor:
European Egyptian Pharmaceutical Industries
Sample Size:
120 patients (60 per arm)
Study Population:
Patients with Diabetic foot ulcer of any stage after proper surgical treatment - if needed. Those patients will be recruited from patients attending the Diabetic foot Center at Faculty of Medicine - Alexandria University and the outpatient clinic at Faculty of Medicine, Cairo University.
Recruitment Period: 9 months
Dose application: thick layer of 2-3 mm applied to the dressing then dressing applied to the ulcer.
Endpoints: Complete healing of the ulcer OR 5 months of application of the ointment whichever comes first
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Design:
This is an open label randomized non-placebo study in which 120 subjects will be randomly allocated to treatment with PedyPhar ointment or Panthenol ointment for their diabetic foot ulcer. Treatment with the ointment will be preceded by appropriate surgical treatment to remove necrotic tissue as indicated by a surgeon for foot ulcer Wagner stages 3-5. Also, diabetic status will be controlled as part of the study. Ointment in either arm will be applied to the ulcer for a maximum of 5 months or till complete healing whichever happens first.
Patients will visit study center every 2 weeks where assessment of the ulcer will be done and patient will be given the ointment for the dressing enough for 2 weeks.
Blood flow in the affected leg will be assessed besides kidney functions complete blood picture besides kidney functions. Diabetic status will be monitored every months and glycosylated hemoglobin will be done every 3 months
Study Duration: 12 months
Study Agent/Intervention Description: PEDYPHAR® is a new patented local ointment composed of natural (Royal Jelly) and (Dexpanthenol) in an innovated, enriched alkaline ointment base.
Dose application: thick layer of 2-3 mm applied to the dressing then dressing applied to the ulcer.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt
- Alexandria University Hospitals
-
Alexandria, Egypt
- Cairo University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult diabetic foot syndrome subjects over 18 years of age of any sex
- All stages of diabetic foot syndrome including Wagner stage 5 - Mid-foot gangrene only after appropriate surgical treatment.
- Patients suffering from type 1 or type 2 diabetes mellitus with diabetic foot syndrome.
- Stable metabolic and pharmacological control at recruitment and during the trial period.
- Adequate perfusion of lower limb as measured by HHD and confirmed by APSV.
Exclusion Criteria:
- Non-diabetic foot ulceration (traumatic, thermal ulceration etc)
- Diabetic foot syndrome graded 5 on Wagner's scale - hind foot gangrene only.
- Any pathological state or disease which can affect the development and outcomes of diabetic foot syndrome such as liver cell failure and renal failure
- Severe limb ischemia (by clinical assessment and HHD) unless re-vascularized.
- Presence of slough or sequestrum unless debrided.
- Hemoglobin less than 8 g/dl unless corrected.
- Those receiving NSAIDs, steroids or anti-mitotic drugs.
- Septicemia patients requiring urgent amputation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pedyphar
Ointment
|
the following will be done to each patient depending on the number of the visit:
Other Names:
|
Active Comparator: Panthenol
Ointment
|
the following will be done to each patient depending on the number of the visit:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Healing of the Ulcer
Time Frame: within 5 months or complete healing whichever comes first
|
within 5 months or complete healing whichever comes first
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
reduction of infection in the ulcer site
Time Frame: 5 months
|
5 months
|
local reaction that may be due to study drug
Time Frame: 5 months
|
5 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Samir H Assaad, PhD, Alexandria University Hospitals
- Principal Investigator: Hesham M Abdel Samad, PhD, Cairo University Hospitals
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Skin Diseases
- Endocrine System Diseases
- Diabetic Angiopathies
- Leg Ulcer
- Skin Ulcer
- Diabetes Complications
- Diabetes Mellitus
- Diabetic Neuropathies
- Foot Diseases
- Diabetic Foot
- Foot Ulcer
- Ulcer
- Physiological Effects of Drugs
- Anti-Infective Agents
- Micronutrients
- Vitamins
- Vitamin B Complex
- Propolis
- Pantothenic Acid
Other Study ID Numbers
- Pedyphar2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot Ulcer
-
University of MinnesotaRecruitingDiabetes Mellitus | Foot Ulcer | Ulcer | Diabetic Foot Ulcer | Foot Ulcer, Diabetic | Ulcer Foot | Ulcer, Leg | Ankle UlcerUnited States
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
University of PadovaUnknownDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Deformities FootItaly
-
Johns Hopkins UniversityWithdrawnDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Mixed | Vascular Ulcer (Arterial or Venous Including Diabetic Ulcers Not Located on the Foot)
-
Corporacion Parc TauliCompletedDiabetic Foot Ulcer | Diabetic Foot Ulcer NeuropathicPakistan
-
Baylor College of MedicineLifeNet HealthCompletedDiabetic Foot Ulcer | Deep Diabetic Foot UlcerUnited States
-
Exciton Technologies Inc.CompletedDiabetic Foot Ulcer | Diabetic Foot Infection | Non-healing Diabetic Foot UlcerCanada
-
National and Kapodistrian University of AthensTerminatedDiabetic Foot | Chronic Diabetic Foot Ulcer of Right Foot | Neuropathic Foot Ulcer | Chronic Diabetic Ulcer of Left Foot (Diagnosis)Greece
-
ETS Wound Care, LLCProfessional Education and Research InstituteCompletedDiabetic Foot | Diabetic Foot Ulcer | Ulcer FootUnited States
-
University of the PunjabHigher Education Commission (Pakistan); Centre of Excellence in Molecular Biology... and other collaboratorsRecruitingDiabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | Chronic Diabetic Ulcer of Left Foot | Chronic Diabetic Foot...Pakistan
Clinical Trials on Royal Jelly and Panthenol (PedyPhar® Ointment)
-
European Egyptian Pharmaceutical IndustriesCompletedDiabetic Foot UlcerEgypt
-
Universidade Federal FluminenseCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsNot yet recruitingCardiovascular Diseases | Hypertension | Chronic Kidney DiseasesBrazil
-
Gonabad University of Medical SciencesMashhad University of Medical SciencesCompleted
-
Manuka HealthCitruslabsActive, not recruiting
-
Manuka HealthCitruslabsActive, not recruiting
-
Circassia LimitedBioskin GmbHCompletedPsoriasis VulgarisGermany
-
PATHTulane University; Liverpool School of Tropical Medicine; Ministry of Health,... and other collaboratorsCompleted
-
HealthpointCompletedDiabetic Foot Ulcers | Diabetic Foot WoundsUnited States, Canada
-
Indonesia UniversityUnknownDiabetes Mellitus, Type 2 | Xerosis CutisIndonesia
-
LEO PharmaCompleted